Abgent Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 51
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Abgent General Information

Description

Developer of primary antibodies. The company primarily provides biological research reagent products such as antibodies, peptides and protein as well as cellular pharmacology, bio-marker discovery, clinical development services.

Contact Information

Website
www.abgent.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 9765 Clairemont Mesa Boulevard
  • Suite C
  • San Diego, CA 92124
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abgent Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abgent‘s full profile, request access.

Request a free trial

Abgent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of primary antibodies. The company primarily provides biological research reagent products such as antibodies,
Other Pharmaceuticals and Biotechnology
San Diego, CA
51 As of 2015
000000&0

00000 00

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
00000 000000000000000 000 0000000000000
Littleton, CO
00 As of 0000
00.00 0000-00-00
000000&0

00000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
00000 000000000000000 000 0000000000000
San Diego, CA
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abgent Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Biologicals Formerly PE-Backed Littleton, CO 00 000000&0
00000000000000 Pending Transaction (PE) San Diego, CA 000 000000000000
0000000 Corporation Houston, TX
00000000, 000 Corporation Hillsborough, NJ
00000000 000000000 Corporation Philadelphia, PA 000000000 -
You’re viewing 5 of 25 competitors. Get the full list »

Abgent Patents

Abgent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8148088-B2 Regulation of autophagy pathway phosphorylation and uses thereof Expired - Fee Related 18-Jul-2008 000000000
US-20120258550-A1 Regulation of autophagy pathway phosphorylation and uses thereof Abandoned 18-Jul-2008 000000000 0
US-20100086541-A1 Regulation of autophagy pathway phosphorylation and uses thereof Granted 18-Jul-2008 000000000 00
US-20100092458-A1 Regulation of apg8 phosphorylation and uses thereof Abandoned 18-Jul-2008 C07K16/44 0

Abgent Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial